Chu-Ping M, Slaughter C A, DeMartino G N
Department of Physiology, University of Texas Southwestern Medical Center, Dallas.
Biochim Biophys Acta. 1992 Mar 12;1119(3):303-11. doi: 10.1016/0167-4838(92)90218-3.
An inhibitory protein for the 20S proteasome (also known as macropain, the multicatalytic proteinase complex and 20S proteinase) has been purified from bovine red blood cells. The inhibitor has an apparent molecular weight of 31,000 on SDS-PAGE and appears to form multimers under nondenaturing conditions. This protein inhibited all three of the putatively distinct catalytic activities of proteasome A (the active form of the proteinase) characterized by the hydrolysis of synthetic peptides such as Z-VLR-MNA, Z-GGL-AMC or Suc-LLVY-AMC and Z-LLE-beta NA. The inhibitor also prevented the hydrolysis of large protein substrates such as casein, lysozyme and bovine serum albumin. Proteasome L (the latent form of the proteinase) does not degrade these large protein substrates, but does hydrolyze the three synthetic peptides at rates similar to those by proteasome A. The inhibitor inhibited only two of these peptidase activities of proteasome L (hydrolysis of Z-GGL-AMC and of Z-LLE-beta NA or Suc-LLVY-AMC); it had no effect on the hydrolysis of Z-VLR-MNA. The inhibitor was specific for inhibition of the proteasome and had no effect on the activity of any other proteinase tested including trypsin, chymotrypsin, papain, subtilisin and both isoforms of calpain. Kinetic analysis indicates that the inhibitor interacted with the proteasome by a mechanism involving tight-binding. Because the proteasome appears to be a key component of the ATP/ubiquitin-dependent pathway of intracellular protein degradation, the inhibitor may represent an important regulatory protein of this pathway.
一种针对20S蛋白酶体(也称为巨肽酶、多催化蛋白酶复合体和20S蛋白酶)的抑制蛋白已从牛红细胞中纯化出来。该抑制剂在SDS-PAGE上的表观分子量为31,000,在非变性条件下似乎形成多聚体。这种蛋白质抑制了蛋白酶体A(蛋白酶的活性形式)的所有三种假定不同的催化活性,这些活性通过合成肽如Z-VLR-MNA、Z-GGL-AMC或Suc-LLVY-AMC以及Z-LLE-βNA的水解来表征。该抑制剂还阻止了酪蛋白、溶菌酶和牛血清白蛋白等大蛋白质底物的水解。蛋白酶体L(蛋白酶的潜伏形式)不会降解这些大蛋白质底物,但以与蛋白酶体A相似的速率水解这三种合成肽。该抑制剂仅抑制蛋白酶体L的其中两种肽酶活性(Z-GGL-AMC以及Z-LLE-βNA或Suc-LLVY-AMC的水解);它对Z-VLR-MNA的水解没有影响。该抑制剂对蛋白酶体的抑制具有特异性,对包括胰蛋白酶、胰凝乳蛋白酶、木瓜蛋白酶、枯草杆菌蛋白酶和两种钙蛋白酶同工型在内的任何其他测试蛋白酶的活性均无影响。动力学分析表明,该抑制剂通过一种涉及紧密结合的机制与蛋白酶体相互作用。由于蛋白酶体似乎是细胞内蛋白质降解的ATP/泛素依赖性途径的关键组成部分,该抑制剂可能代表了这条途径的一种重要调节蛋白。